myelodysplastic syndrome

March 20, 2018March 20, 2018

Rich’s RP-323 Shows Activity Against Hodgkin’s Lymphoma in Phase 1 Trial

News

Experimental therapy RP-323 has shown anticancer activity against Hodgkin’s lymphoma in a Phase 1 trial. Its developer, Rich Pharmaceuticals, is now planning to evaluate the therapy in human clinical trials for the disease. ... Read more

April 13, 2017April 13, 2017

Argenx Begins Phase 2 Trial of ARGX-110 for Cutaneous T-cell Lymphoma

News

A Phase 2 trial evaluating the anti-CD70 antibody ARGX-110 in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL) has begun dosing participants, argenx announced. “We have previously observed evidence of ... Read more

March 5, 2016

Blood Cancers Explained: Lymphoma, Leukemia, Myeloma, and more

In this LEARNBLOOD video, watch “a short and simple animated film which will help you gain a basic understanding of leukemia, myeloma, lymphoma, myelodysplastic syndrome, and the myeloproliferative diseases including myelofibrosis. These are ... Read more

February 16, 2016May 13, 2016

HOPA Launches ‘Emerging Issues in Oncology’ Webinar Series for Recertification

News

The recently developed Board Certified Oncology Pharmacist (BCOP) Recertification Program has been launched by the Hematology/Oncology Pharmacy Association (HOPA) with the first in a series of five Emerging Issues in Oncology ... Read more